New insider activity at Staar Surgical ( (STAA) ) has taken place on March 21, 2025.
Director Broadwood Partners Lp has made a significant investment in Staar Surgical by purchasing 201,844 shares of the company’s stock. This transaction is valued at a substantial $3,585,349, indicating a strong vote of confidence in the company’s future prospects.
Recent Updates on STAA stock
Staar Surgical has recently undergone significant leadership changes, with Warren Foust promoted to President and COO, and Magda Michna appointed as Chief Development Officer. These changes are part of a broader strategy to streamline operations, improve cost structure, and enhance shareholder value. The company is also facing challenges in its global growth, particularly in China, which has led to a revision of its price target by analysts. The leadership transition, including the appointment of Stephen C. Farrell as President and CEO, is aimed at leveraging his healthcare industry experience to navigate these challenges and drive growth in the refractive surgery market.
More about Staar Surgical
YTD Price Performance: -24.27%
Average Trading Volume: 1,037,976
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $901.7M